Kanwar Singh, MD; G. Dennis Shanks, MD; Henry Wilde, MD
This content is PDF only. Please click on the PDF icon to access.
To the Editors: Mefloquine, 250 mg weekly starting 1 week before travel and ending 4 weeks after departure from areas in which malaria is endemic, has been recommended in the United States for prophylaxis in travelers to areas where chloroquine-resistant falciparum malaria has been reported (1). Although minor side effects, such as dizziness and vomiting, were commonly reported in a placebo-controlled, double-blinded trial in U.S. soldiers deployed to Thailand, weekly mefloquine was generally well tolerated (2). A study of 3386 European tourists returning from Africa who received mefloquine indicated only one possibly drug-related reaction (depression), and there were no reports
Singh K, Shanks GD, Wilde H. Seizures after Mefloquine. Ann Intern Med. 1991;114:994. doi: 10.7326/0003-4819-114-11-994_1
Download citation file:
Published: Ann Intern Med. 1991;114(11):994.
Neurology, Seizure Disorders.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use